The latest international news, analysis and features on the HIV epidemic from AVERT. Share your views and expertise with your peers in the comments box below the articles.
Progress in halting TB – the world’s leading infectious disease killer – is plagued by a lack of political will and inequalities in healthcare access
Women in Nigeria face cycles of stigma and poverty that severley limit their access to HIV serivces, including the prevention of mother-to-child transmission services.
Expanding access to treatment for people living with HIV is shown to decrease tuberculosis (TB) incidence – but it is not the silver bullet.
Study in South Africa and Burkina Faso shows that simple HPV screening could help save lives in places with limited health infrastructure.
Kenya becomes first country in the world to introduce child-friendly tuberculosis (TB) medicine. It is hoped that the roll-out of this medication will drastically reduce the number of child TB deaths in the country.
The natural ability of some children's immune systems to hold off attacking HIV, thus stopping diseases progression, may provide clues for future treatment.
3,000 people have been killed in drug-related crackdowns. This hard-line stance threatens to derail the HIV response in the country, as harm reduction services face mounting pressure to close.
Zambian officials promote absitinence in prisons, turning a blind eye to the HIV prevention needs of men who have sex with men
Nearly US$ 13 billion has been pledged to the Global Fund to Fight AIDS, Tuberculosis and Malaria, to accelerate the response to end these diseases over the next three years.
The European Commission has given pharmaceutical company, Gilead, the green light to market Truvada as pre-exposure prophylaxis (PrEP) across the region.